The Recruitment of Raf-1 to Membranes is Mediated by Direct Interaction with Phosphatidic Acid and is Independent of Association with Ras
Overview
Authors
Affiliations
The serine/threonine kinase Raf-1 is an essential component of the MAPK cascade. Activation of Raf-1 by extracellular signals is initiated by association with intracellular membranes. Recruitment of Raf-1 to membranes has been reported to be mediated by direct association with Ras and by the phospholipase D product phosphatidic acid (PA). Here we report that insulin stimulation of HIRcB fibroblasts leads to accumulation of Ras, Raf-1, phosphorylated MEK, phosphorylated MAPK, and PA on endosomal membranes. Mutations that disrupt Raf-PA interactions prevented recruitment of Raf-1 to membranes, whereas disruption of Ras-Raf interactions did not affect agonist-dependent translocation. Expression of a dominant-negative Ras mutant did not prevent insulin-dependent Raf-1 translocation, but inhibited phosphorylation of MAPK. Finally, the PA-binding region of Raf-1 was sufficient to target green fluorescent protein to membranes, and its overexpression blocked recruitment of Raf-1 to membranes and disrupted insulin-dependent MAPK phosphorylation. These results indicate that agonist-dependent Raf-1 translocation is primarily mediated by a direct interaction with PA and is independent of association with Ras.
NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia.
Chen C, Su C, Huang C, Huang X, Cuili X, Chao T Nat Commun. 2024; 15(1):2264.
PMID: 38480688 PMC: 10938004. DOI: 10.1038/s41467-024-46385-7.
Bozelli Jr J, Epand R Cancers (Basel). 2022; 14(21).
PMID: 36358678 PMC: 9655555. DOI: 10.3390/cancers14215259.
Parkin coordinates mitochondrial lipid remodeling to execute mitophagy.
Lin C, Yan J, Kapur M, Norris K, Hsieh C, Huang D EMBO Rep. 2022; 23(12):e55191.
PMID: 36256516 PMC: 9724658. DOI: 10.15252/embr.202255191.
May-Dracka T, Gao F, Hopkins B, Hronowski X, Chen T, Chodaparambil J ACS Med Chem Lett. 2022; 13(4):665-673.
PMID: 35450377 PMC: 9014516. DOI: 10.1021/acsmedchemlett.1c00682.
Delivering Glioblastoma a Kick-DGKα Inhibition as a Promising Therapeutic Strategy for GBM.
Purow B Cancers (Basel). 2022; 14(5).
PMID: 35267577 PMC: 8909282. DOI: 10.3390/cancers14051269.